Skip to content
Screener

Lantheus Holdings LNTH Shares (Diluted)

Shares (Diluted) at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
454M-0.9%
Immunome logo
ImmunomeIMNM
113.1M+42.5%
Perspective Therapeutics logo
Perspective TherapeuticsCATX
103.6M+43.2%
RadNet logo
RadNetRDNT
77.1M+3.6%
BillionToOne, Inc. logo
BillionToOne, Inc.BLLN
54.5M+424%
CTO
Citius Oncology, Inc.CTOR
100M+39.8%

Other financials

Income statement

See full
Revenue$388.2M+2.7%
Gross profit$241.9M+0.4%
Operating income$100.2M+13.9%
Net income$75.0M-4.7%
EPS (diluted)$1.11-0.9%

Balance sheet

See full
Cash & equivalents$595.0M-14.7%
Total debt$626.8M+1.5%
Total equity$1.3B+12.4%
Total assets$2.4B+14.1%

Cash flow

See full
Operating cash flow$92.2M+5.9%
CapEx$2.3M-70.7%
Free cash flow$89.9M+13.5%

Valuation

See full
Market cap$6.63B+84.6%
Enterprise value$6.66B+89.7%
P/E24.1×+11.4×
P/S4.3×+1.9×

Profitability

See full
Gross margin60.1%-3.6pp
Operating margin19.4%-9.4pp
Net margin17.7%-0.9pp
FCF margin24.9%-6.6pp

Returns & leverage

See full
Return on equity22.2%-3.6pp
Debt / equity0.5×-0.1×
Current ratio3.1×-1.2×

Where this comes from

Reported directly by Lantheus Holdings in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Lantheus Holdings’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:01 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336795
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Income tax expense18,79625,76256,78449,346
Net income$75,029$78,755$193,446$151,700
Net income per common share:
Basic$1.15$1.15$2.98$2.21
Diluted$1.11$1.12$2.91$2.14
Weighted average common shares outstanding:
Basic65,16068,51664,94968,591
Diluted67,51870,31266,37970,896

Item 1. Financial Statements

FAQ

What is Lantheus Holdings's shares (diluted)?
Lantheus Holdings (LNTH) reported shares (diluted) of 67.5M in Q2 2026.
How has Lantheus Holdings's shares (diluted) changed year-over-year?
Lantheus Holdings's shares (diluted) decreased by 4.0% year-over-year, from 70.3M to 67.5M.
What is the long-term trend for Lantheus Holdings's shares (diluted)?
Over 4 years (2021 to 2025), Lantheus Holdings's shares (diluted) has grown at a 0.7% compound annual growth rate (CAGR), from 270.3M to 277.9M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Lantheus Holdings's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude